Sarah C Tinker1, Suzan L Carmichael2, Marlene Anderka3, Marilyn L Browne4, Kristin M Caspers Conway5, Robert E Meyer6, Wendy N Nembhard7, Richard S Olney1, Jennita Reefhuis1. 1. National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia. 2. Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University, Stanford, California. 3. Center for Birth Defects Research and Prevention at the Massachusetts Department of Public Health, Boston, Massachusetts. 4. Congenital Malformations Registry, New York State Department of Health, Albany, New York. 5. Department of Epidemiology, College of Public Health, The University of Iowa, Iowa City, Iowa. 6. Birth Defects Monitoring Program, State Center for Health Statistics, North Carolina Division of Public Health, Raleigh, North Carolina. 7. Department of Pediatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
Abstract
BACKGROUND: The Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS) is a population-based, multi-Center case-control study of modifiable risk factors for selected birth defects in the United States. BD-STEPS is the second major research effort of the Centers for Birth Defects Research and Prevention, which extends and expands the initial research effort, the National Birth Defects Prevention Study (NBDPS). METHODS: BD-STEPS focuses on 17 categories of structural birth defects selected based on severity, prevalence, consistent ascertainment, and previous findings that warrant additional research. Cases are identified through existing birth defects surveillance programs; controls are from vital records or birth hospital logs from the same catchment area. BD-STEPS uses a standardized computer-assisted telephone interview to collect information from case and control mothers on topics including demographics, health conditions, and medication use. Following the maternal interview, selected Centers request permission to sample residual newborn screening blood spots from state repositories for genetic analyses. New components planned for BD-STEPS include linkages with external datasets and use of online questionnaires to collect in-depth information on selected exposures. RESULTS: BD-STEPS extends NBDPS by continuing to collect data on many exposures that were assessed in NBDPS, allowing data from both studies to be combined and providing an unprecedented sample size to analyze rare exposures. BD-STEPS expands upon NBDPS by collecting more detailed information on existing exposures as well as new exposures. CONCLUSION: The goal of BD-STEPS is to provide women and healthcare providers with information they need to make decisions to promote the healthiest pregnancy possible.
BACKGROUND: The Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS) is a population-based, multi-Center case-control study of modifiable risk factors for selected birth defects in the United States. BD-STEPS is the second major research effort of the Centers for Birth Defects Research and Prevention, which extends and expands the initial research effort, the National Birth Defects Prevention Study (NBDPS). METHODS: BD-STEPS focuses on 17 categories of structural birth defects selected based on severity, prevalence, consistent ascertainment, and previous findings that warrant additional research. Cases are identified through existing birth defects surveillance programs; controls are from vital records or birth hospital logs from the same catchment area. BD-STEPS uses a standardized computer-assisted telephone interview to collect information from case and control mothers on topics including demographics, health conditions, and medication use. Following the maternal interview, selected Centers request permission to sample residual newborn screening blood spots from state repositories for genetic analyses. New components planned for BD-STEPS include linkages with external datasets and use of online questionnaires to collect in-depth information on selected exposures. RESULTS: BD-STEPS extends NBDPS by continuing to collect data on many exposures that were assessed in NBDPS, allowing data from both studies to be combined and providing an unprecedented sample size to analyze rare exposures. BD-STEPS expands upon NBDPS by collecting more detailed information on existing exposures as well as new exposures. CONCLUSION: The goal of BD-STEPS is to provide women and healthcare providers with information they need to make decisions to promote the healthiest pregnancy possible.
Authors: Genoveva C E Keustermans; Sanne B E Hoeks; Jenny M Meerding; Berent J Prakken; Wilco de Jager Journal: Methods Date: 2013-04-19 Impact factor: 3.608
Authors: Marlene T Anderka; Angela E Lin; Dianne N Abuelo; Allen A Mitchell; Sonja A Rasmussen Journal: Am J Med Genet A Date: 2009-06 Impact factor: 2.802
Authors: Jean D Brender; Peter J Weyer; Paul A Romitti; Binayak P Mohanty; Mayura U Shinde; Ann M Vuong; Joseph R Sharkey; Dipankar Dwivedi; Scott A Horel; Jiji Kantamneni; John C Huber; Qi Zheng; Martha M Werler; Katherine E Kelley; John S Griesenbeck; F Benjamin Zhan; Peter H Langlois; Lucina Suarez; Mark A Canfield Journal: Environ Health Perspect Date: 2013-06-14 Impact factor: 9.031
Authors: Jeanette A Stingone; Thomas J Luben; Julie L Daniels; Montserrat Fuentes; David B Richardson; Arthur S Aylsworth; Amy H Herring; Marlene Anderka; Lorenzo Botto; Adolfo Correa; Suzanne M Gilboa; Peter H Langlois; Bridget Mosley; Gary M Shaw; Csaba Siffel; Andrew F Olshan Journal: Environ Health Perspect Date: 2014-04-11 Impact factor: 9.031
Authors: Erin C Peckham-Gregory; Kenneth L McClain; Carl E Allen; Michael E Scheurer; Philip J Lupo Journal: Ann Epidemiol Date: 2018-04-17 Impact factor: 3.797
Authors: Albeliz Santiago-Colón; Carissa M Rocheleau; Stephen Bertke; Annette Christianson; Devon T Collins; Emma Trester-Wilson; Wayne Sanderson; Martha A Waters; Jennita Reefhuis Journal: Ann Work Expo Health Date: 2021-07-03 Impact factor: 2.179
Authors: Christina D Chambers; Jerry A Krishnan; Lorene Alba; Jessica D Albano; Allison S Bryant; Melanie Carver; Lee S Cohen; Elena Gorodetsky; Sonia Hernandez-Diaz; Margaret A Honein; Bridgette L Jones; Richard K Murray; Jennifer A Namazy; Leyla Sahin; Catherine Y Spong; Kaveeta P Vasisht; Kevin Watt; Keele E Wurst; Lynne Yao; Michael Schatz Journal: J Allergy Clin Immunol Date: 2021-03-10 Impact factor: 14.290
Authors: Chibuzor Franklin Ogamba; Alero Ann Roberts; Ochuwa Adiketu Babah; Chibuikem Anthony Ikwuegbuenyi; Oluwaseun Joseph Ologunja; Oluyinka Kehinde Amodeni Journal: Pan Afr Med J Date: 2021-03-28